One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Anticipating the future of cancer care in Trump's America
doi : 10.1016/S1470-2045(24)00669-7
Volume 25, Issue 12, December 2024, Page 1507
Early switch maintenance in gastric cancer: who benefits most?
Tomoki Sakakida a, Shigenori Kadowaki a
Secondary cytoreductive surgery with HIPEC: a promising therapeutic option for recurrent ovarian cancer
Taymaa May a b
Locoregionally advanced nasopharyngeal carcinoma: integrating immunotherapy into definitive treatment
Dora L W Kwong a
Patients with head and neck cancer unfit for cisplatin—what next?
Naomi Kiyota a
The power of three: hypofractionation, protons, and molecular imaging in glioblastoma radiotherapy
Eric A Mellon a
The trade-off between accelerated cancer drug approvals and patient preferences
Dario Trapani a b, Nirmala Bhoo-Pathy c
Balancing clinical benefit and social value: challenges in HTA assessments
Haydee Verduzco-Aguirre a b c, Brooke E Wilson a b
Retrospective analysis of immunotherapy outcomes in Black patients
Kerry L Reynolds a, Pauline Funchain b
Retraction and republication—Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
The Editors of The Lancet Oncology a
Investing in cancer care in the UK: why aren't we acting on the evidence?
Zachary J Ward a, Rifat Atun a b, Ajay Aggarwal c d, Mark Lawler e f, Hedvig Hricak g
Cancer care, education, and research in the South Asian Association for Regional Cooperation (SAARC) countries
Cheryl Reeves a, David Collingridge a
Capturing the true effect of anti-PD-1 therapy on patients’ health-related quality of life
Mees D Egeler a b, Lonneke V van de Poll-Franse b
Capturing the true effect of anti-PD-1 therapy on patients’ health-related quality of life – Authors' reply
Emanuel Bührer a, Michal Kicinski a, Madeline Pe a, Corneel Coens a, Alexander M M Eggermont b c
Palliative radiotherapy for hepatic cancer pain
Ze Xiang a, Jiarui Li a, Jian Wu b
Palliative radiotherapy for hepatic cancer pain
Chi Yan Wong a, Kwok Ying Chan a b, Kwok Wai Tsang a, Wai Kit Lam a
Palliative radiotherapy for hepatic cancer pain
Xianwen Liang a, Jincai Wu a, Hui Liu b
Palliative radiotherapy for hepatic cancer pain – Authors' reply
Laura A Dawson a b, Dongsheng Tu c, Christopher J O'Callaghan c
Decentralised clinical trials: a game changer for improved access to clinical trials
Craig Underhill a, Sabe Sabesan b, Elizabeth Wilson c
New funding for Indigenous-led cancer research and nationwide clinical trials in Australia
Tony Kirby
European Commission highlights policies to support return to work for patients with cancer and survivors
Talha Burki
Final phase of HPV vaccination campaign launched in Bangladesh
Udani Samarasekera
Impact of radiopharmaceutical shortage prompts questions on UK resilience
Emma Wilkinson
Group of UK MPs urge colleagues to support assisted dying bill
Sharmila Devi
New Zealand doctors raise alarm about cancer drugs inequity
Tony Kirby
American Lung Association calls for expanded insurance coverage for lung cancer screening
Bryant Furlow
Former big tobacco employee no longer part of UK Government cancer advisory committee
Tony Kirby
Cancer prevention, care, and outreach among the Rohingya refugee population in Bangladesh
Mohiuddin A K Chowdhury a b, Tuhin Biswas c, Tofrida Rahman a, Omar Salma a, Mizana a, Heath Devin Skinner f, Stephen Avery d g, Wilfred Ngwa d e g, M Saiful Huq d f g
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial
Giovanni Randon MD a, Sara Lonardi MD b, Prof Matteo Fassan MD c d, Federica Palermo BS a, Stefano Tamberi MD e, Elisa Giommoni MD PhD f, Carlotta Ceccon BS c, Samantha Di Donato MD PhD g, Lorenzo Fornaro MD h, Oronzo Brunetti MD i, Ferdinando De Vita MD j, Alessandro Bittoni MD k, Claudio Chini MD l, Andrea Spallanzani MD PhD m, Floriana Nappo MD b, Valerie Bethaz MD n, Antonia Strippoli MD o, Tiziana Latiano MD p, Giovanni Gerardo Cardellino MD q, Francesco Giuliani MD i r…Filippo Pietrantonio MD a
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial
Prof Jean-Marc Classe MD a b, Pierre Meeus MD c, Delphine Hudry MD d, Romuald Wernert MD e, François Quenet MD f, Prof Frédéric Marchal MD g, Prof Gilles Houvenaeghel MD h, Anne-Sophie Bats MD i, Prof Fabrice Lecuru MD i †, Gwenaël Ferron MD j, Prof Cécile Brigand MD k, Dominique Berton MD a, Laurence Gladieff MD j, Prof Florence Joly MD l m, Isabelle Ray-Coquard MD c, Sylvaine Durand-Fontanier MD n, Gabriel Liberale MD o, Prof Marc Pocard MD p q, Constantin Georgeac MD r, Sébastien Gouy MD s t…Prof Olivier Glehen MD y z
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
Sai-Lan Liu MD a f *, Xiao-Yun Li MD a f *, Jin-Hao Yang MD a f *, Dong-Xiang Wen MD a f *, Shan-Shan Guo MD a f *, Li-Ting Liu MD a f *, Yi-Fu Li MD a f *, Mei-Juan Luo MD b f, Si-Yi Xie MD a f, Yu-Jing Liang MD b f, Xue-Song Sun MD a f, Zhen-Chong Yang MD c f, Xiao-Fei Lv MD b f, Prof Dong-Hua Luo MD a f, Ji-Bin Li PhD d f, Prof Qing Liu PhD d f, Pan Wang MD a f, Prof Ling Guo MD a f, Prof Hao-Yuan Mo MD a f, Prof Rui Sun MD a f…Prof Hai-Qiang Mai MD a f â€
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial
Prof Loren K Mell MD a, Pedro A Torres-Saavedra PhD b, Prof Stuart J Wong MD c, Prof Julie A Kish MD d, Steven S Chang MD e, Prof Richard C Jordan DDS PhD f, Tian Liu PhD g, Prof Minh Tam Truong MD h, Prof Eric W Winquist MD i, Vinita Takiar MD PhD j, Trisha Wise-Draper MD PhD k, Prof Jared R Robbins MD l, Prof Cristina P Rodriguez MD m, Musaddiq J Awan MD n, Beth M Beadle MD PhD o, Christina Henson MD p, Samir Narayan MD q, Prof Sharon A Spencer MD r, Steven Powell MD s, Prof Neal Dunlap MD t…Quynh-Thu Le MD o
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study
Dai Maruyama MD a b, Eric Jacobsen MD c, Prof Pierluigi Porcu MD d, Pamela Allen MD e, Prof Kenji Ishitsuka MD f, Shigeru Kusumoto MD g, Tomoko Narita MD g, Kensei Tobinai MD a, Prof Francine Foss MD h, Prof Kunihiro Tsukasaki MD i, Tatyana Feldman MD j, Yoshitaka Imaizumi MD k l, Koji Izutsu MD a, Satoko Morishima MD m, Nobuhiko Yamauchi MD n, Junichiro Yuda MD n, Jonathan E Brammer MD o, Toyotaka Kawamata MD p q, Prof Jia Ruan MD r, Kisato Nosaka MD s…Steven M Horwitz MD y
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
Prof Pier Luigi Zinzani MD a, Koji Izutsu MD b, Neha Mehta-Shah MD c, Stefan K Barta MD d, Prof Kenji Ishitsuka MD e, Raul Córdoba MD f, Shigeru Kusumoto MD g, Emmanuel Bachy MD h, Kate Cwynarski PhD i, Giuseppe Gritti MD j, Anca Prica MD k, Eric Jacobsen MD l, Tatyana Feldman MD m, Yann Guillermin MD n, Daisuke Ennishi MD o, Dok Hyun Yoon MD p, Eva Domingo Domenech MD q, Prof Jasmine Zain MD r, Jie Wang MD s, Prof Jin Seok Kim MD t…Steven M Horwitz MD w
The current and future global burden of cancer among adolescents and young adults: a population-based study
Taylor Hughes MSc a, Andrew Harper MSc c, Sumit Gupta PhD d, Prof A Lindsay Frazier MD e, Prof Winette T A van der Graaf MD f, Florencia Moreno MD g, Adedayo Joseph MD h i, Miranda M Fidler-Benaoudia PhD a b c
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial
Prof Sujay Vora MD a, Deanna Pafundi PhD d, Molly Voss BS e, Matthew Buras MS e, Jonathan Ashman MD a, Prof Bernard R Bendok MD b, William Breen MD h, Leland Hu MD f, Sani Kizilbash MD i, Prof Nadia Laack MD h, Prof Wei Liu PhD a, Prof Anita Mahajan MD h, Prof Maciej Mrugala MD c, Prof Alyx Porter MD c, Michael Ruff MD j, Prof Terence Sio MD a, Prof Joon Uhm MD j, Ming Yang MD g, Debra Brinkmann PhD h, Prof Paul Brown MD h
Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment
Robin Forrest MSc a, Mylene Lagarde PhD a, Prof Ajay Aggarwal MD PhD b, Huseyin Naci PhD a
Use of the ESMO-Magnitude of Clinical Benefit Scale to guide HTA recommendations on coverage and reimbursement for cancer medicines: a retrospective analysis
Panos Kanavos PhD a, Erica Visintin PhD a, Aris Angelis PhD a
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis
Luca Mastrantoni MD a b *, Marta Chiaravalli MD a b *, Alexia Spring MD a b, Viria Beccia MD a b, Armando Di Bello MD a b, Cinzia Bagalà MD PhD b, Maria Bensi MD PhD b, Diletta Barone MD a b, Giovanni Trovato MD a b, Giulia Caira MD a b, Giulia Giordano MD c, Prof Emilio Bria MD a b d, Prof Giampaolo Tortora MD PhD a b †, Lisa Salvatore MD PhD a b â€
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study
Sean Miller MD a c, Ralph Jiang MS d, Prof Matthew Schipper PhD d, Lars G Fritsche PhD d e, Garth Strohbehn MD f h i j, Beth Wallace MD b g h o, Daria Brinzevich MD f j, Virginia Falvello MD f j, Benjamin H McMahon PhD k, Rafael Zamora-Resendiz BS l, Prof Nithya Ramnath MBBS f i j, Xin Dai PhD m, Kamya Sankar MD n, Donna M Edwards MD PhD a c, Steven G Allen MD PhD a c, Shinjae Yoo PhD m, Silvia Crivelli PhD l, Michael D Green MD PhD a c f, Alex K Bryant MD MAS a c f h
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
Prof Hope S Rugo MD a, Florence Lerebours MD b, Prof Eva Ciruelos MD c, Pamela Drullinsky MD d, Manuel Ruiz-Borrego MD e, Prof Patrick Neven MD f, Prof Yeon Hee Park MD g, Prof Aleix Prat MD h, Thomas Bachelot MD i, Dejan Juric MD j, Nicholas Turner MD k, Nickolas Sophos MS l, Juan Pablo Zarate MD l, Christina Arce BS l, Yu-Ming Shen PhD m, Prof Stuart Turner MPH l, Hemanth Kanakamedala BS n, Wei-Chun Hsu MS o, Prof Stephen Chia MD p
Cancer care and outreach in South Asian Association for Regional Cooperation (SAARC) countries: from epidemiology and the National Cancer Control Programme to screening, diagnosis, and treatment
Prof M Saiful Huq PhD a b, Sandhya C Acharya MD c, Susmita Sharma MD d, Saugat Poudyal MD c, Simit Sapkota MD e, Sunil Shrestha PhD f, Manish Gautam MDevs g, Sudhir R Silwal MD h, Mohammad M Haque MPH i, A F M Kamal Uddin MD j, Sanjeeva Gunasekara MD k, Prof K Govind Babu DM l, Ugyen Tshomo MD m, Ahmad J Safi MD n, Prof Ahmed I Masood MD o, Mostafa A Sumon MD p, Prof Mohammad A Hai DMRT q, Altaf Hossain MD r, Shaila Purvin MBA s, Prof Heath Devin Skinner MD a b…Prof Krishni Wijesooriya PhD v
Cancer care and outreach in the South Asian Association for Regional Cooperation (SAARC) region: overcoming barriers and addressing challenges
Prof M Saiful Huq PhD a, Sandhya C Acharya MD b, Saugat Poudyal MD b, Susmita Sharma MD c, Sudhir R Silwal MD d, Simit Sapkota MD e, Manish Gautam MDevs f, Mohammad M Haque MPH g, A F M Kamal Uddin MD h, Sanjeeva Gunasekara MD i, Prof K Govind Babu DM j, Ugyen Tshomo MD k, Ahmad J Safi PhD l, Prof Ahmed I Masood MD m, Mostafa A Sumon MD n, Shaila Purvin MBA o, Prof Mohammad A Hai DMRT p, Prof Heath Devin Skinner MD PhD a, Prof Stephen Avery PhD q, Prof Wilfred Ngwa PhD r…Prof Krishni Wijesooriya PhD s
Cancer education and training within the South Asian Association for Regional Cooperation (SAARC) countries
Prof M Saiful Huq PhD a b, Sandhya C Acharya MD c, Simit Sapkota MD d, Sudhir R Silwal MD e, Manish Gautam MDevs f, Susmita Sharma MD g, Saugat Poudyal MD c, Mostafa A Sumon MD h, Tasneem Hossain MD i, A F M Kamal Uddin MD j, Sanjeeva Gunasekara MD k, Prof K Govind Babu DM l, Prof Hemant Malhotra MD m, Ugyen Tshomo MD n, Ahmad J Safi PhD o, Prof Ahmed I Masood MD p, Shaila Purvin MBA q, Prof Mohammad A Hai DMRT r, Syed MA Islam MD s, Towhidul Islam MD s…Prof Krishni Wijesooriya PhD v
Cancer research in South Asian Association for Regional Cooperation (SAARC) countries
Prof M Saiful Huq PhD a b, Sandhya C Acharya MD c, Manish Gautam MDevs d, Sudhir R Silwal MD e, Simit Sapkota MD f, Saugat Poudyal MD c, Susmita Sharma MD g, Prof K Govind Babu DM h, Taslima Nigar MS i, Shahana Pervin MD i, Seema Gulia DM j, Sanjeeva Gunasekara MD k, A F M Kamal Uddin MD l, Ugyen Tshomo MD m, Ahmad J Safi PhD n, Mohammad S Nadeem MD o, Prof Ahmed I Masood MD p, Mostafa A Sumon MD q, Shaila Purvin MBA r, Prof Mohammad A Hai DMRT s…Prof Krishni Wijesooriya PhD v
Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health
Oluwatobi T Arisa PhD a, Erica L Beatson BS d, Annieka Reno BS a, Cindy H Chau PhD d, Rosemarie Aurigemma PhD e, Patricia S Steeg PhD b c, William D Figg PharmD a c d
Artificial intelligence-aided data mining of medical records for cancer detection and screening
Amalie Dahl Haue MD PhD a b, Jessica Xin Hjaltelin PhD a, Peter Christoffer Holm PhD a, Davide Placido PhD a b, S⊘ren Brunak PhD a b
Acute lymphoblastic leukaemia relapse presenting as optic nerve infiltration
Khushboo Chauhan MD a, Vishal Ramesh Raval MD a b
